Online Exclusive »

Breaking News: Injectable Aripiprazole Reduces Schizophrenia Hospitalizations

SAN FRANCISCO—Treatment with the once-monthly injectable form of aripiprazole significantly reduced rates of hospitalization in patients with schizophrenia, according to the preliminary results of a multi-center, mirror-image study. The study data were presented in a poster at the annual meeting of the American Psychiatric Association (APA).


Current Issue

AMCP Conference »

AMCP Looks to the Future

Edith Rosato, RPh, began her position as AMCP’s chief executive officer in October 2011, coinciding with unprecedented change in the healthcare industry. Economic conditions were weak, and companies were preparing for provisions in the Patient Protection and Affordable Care Act (ACA).

The uncertainty remains due to the lingering effects of the recession and the ACA not fully being implemented until next year. Still, Ms. Rosato has taken steps to guide AMCP’s evolution and help its members stay abreast with the transformations.




Pharmaceutical News

Healthcare News

Trends Report

Get your Trends Smart Phone Mobile App Now! Use your smart phone to navigate to www.firstreporttrends.com to download this FREE App.